These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35017743)

  • 21. [2019 Coronavirus disease (COVID-19): contribution of rheumatology].
    Nasonov EL
    Ter Arkh; 2021 May; 93(5):71504. PubMed ID: 36286708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance.
    Wallace ZS; Bhana S; Hausmann JS; Robinson PC; Sufka P; Sirotich E; Yazdany J; Grainger R
    Rheumatology (Oxford); 2020 Jun; 59(6):1204-1206. PubMed ID: 32374851
    [No Abstract]   [Full Text] [Related]  

  • 23. The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta
    Monti S; Montecucco C
    Ann Rheum Dis; 2021 Jan; 80(1):e3. PubMed ID: 32340978
    [No Abstract]   [Full Text] [Related]  

  • 24. COVID-19, rheumatic diseases and immune dysregulation-a perspective.
    Tariq S; Van Eeden C; Tervaert JWC; Osman MS
    Clin Rheumatol; 2021 Feb; 40(2):433-442. PubMed ID: 33411143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global Perspective on the Impact of the COVID-19 Pandemic on Rheumatology and Health Equity.
    Hsieh E; Dey D; Grainger R; Li M; Machado PM; Ugarte-Gil MF; Yazdany J
    Arthritis Care Res (Hoboken); 2024 Jan; 76(1):22-31. PubMed ID: 37277949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global rheumatology alliance registry.
    Int J Rheum Dis; 2021 Sep; 24(9):1224. PubMed ID: 34469058
    [No Abstract]   [Full Text] [Related]  

  • 27. African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic.
    Akintayo RO; Bahiri R; El Miedany Y; Olaosebikan H; Kalla AA; Adebajo AO; Migowa AN; Slimani S; Koussougbo OD; Kawther BA; Akpabio AA; Ghozlani I; Dey D; Hassan WA; Govind N; Makan K; Mohamed A; Genga EK; Ghassem MKA; Mortada M; Hamdi W; Wabi MO; Tikly M; Ngandeu-Singwe M; Scott C
    Clin Rheumatol; 2021 Sep; 40(9):3445-3454. PubMed ID: 32876786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global rheumatology alliance registry.
    Int J Rheum Dis; 2021 Nov; 24(11):1442. PubMed ID: 34724598
    [No Abstract]   [Full Text] [Related]  

  • 29. Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology Alliance.
    Robinson PC; Yazdany J; Machado PM
    Curr Opin Rheumatol; 2021 Mar; 33(2):111-116. PubMed ID: 33394601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].
    Schulze-Koops H; Holle J; Moosig F; Specker C; Aries P; Burmester G; Fiehn C; Hoyer B; Krause A; Leipe J; Lorenz HM; Schneider M; Sewerin P; Voormann A; Wager U; Krüger K; Iking-Konert C;
    Z Rheumatol; 2020 May; 79(4):385-388. PubMed ID: 32342184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virtual rheumatology appointments during the COVID-19 pandemic: an international survey of perspectives of patients with rheumatic diseases.
    Howren A; Aviña-Zubieta JA; Rebić N; Dau H; Gastonguay L; Shojania K; Davidson E; De Vera MA
    Clin Rheumatol; 2020 Nov; 39(11):3191-3193. PubMed ID: 32803570
    [No Abstract]   [Full Text] [Related]  

  • 32. Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global Rheumatology Alliance Registry.
    Int J Rheum Dis; 2021 Mar; 24(3):466. PubMed ID: 33710789
    [No Abstract]   [Full Text] [Related]  

  • 33. Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic disease.
    Robinson PC; Kim AHJ
    Best Pract Res Clin Rheumatol; 2021 Mar; 35(1):101664. PubMed ID: 33610466
    [No Abstract]   [Full Text] [Related]  

  • 34. Rheumatology in a time of Coronavirus: lessons from our early experiences.
    Cronin O; Horne A; Ralston SH
    QJM; 2020 Oct; 113(10):715-716. PubMed ID: 32396603
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of Apremilast in Patients With Psoriatic Arthritis During the COVID-19 Pandemic: Comment on the Article by Mikuls et al.
    Bansal P; Goyal A; Cusick A; Aslam F
    Arthritis Rheumatol; 2021 Mar; 73(3):547-548. PubMed ID: 33142038
    [No Abstract]   [Full Text] [Related]  

  • 36. How did COVID-19 pandemic changed the Portuguese rheumatology?
    Vieira-Sousa E; Fonseca JE; Santos MJ
    Acta Reumatol Port; 2020 Jun; 45(Jan-Mar (1)):5-6. PubMed ID: 32529820
    [No Abstract]   [Full Text] [Related]  

  • 37. COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence.
    Costantino F; Bahier L; Tarancón LC; Leboime A; Vidal F; Bessalah L; Breban M; D'Agostino MA
    Joint Bone Spine; 2021 Jan; 88(1):105095. PubMed ID: 33152484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic].
    Hasseli R; Pfeil A; Hoyer BF; Lorenz HM; Regierer AC; Richter JG; Schmeiser T; Strangfeld A; Voll RE; Krause A; Schulze-Koops H; Müller-Ladner U; Specker C
    Z Rheumatol; 2021 Sep; 80(7):641-646. PubMed ID: 34196793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. #Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic.
    Ruffer N; Knitza J; Krusche M
    Rheumatol Int; 2020 Dec; 40(12):2031-2037. PubMed ID: 32995894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry.
    Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Østergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Nørgaard Agerbo J; Ziegler C; Lund Hetland M
    RMD Open; 2021 May; 7(2):. PubMed ID: 33941664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.